Is Canopy Growth (TSX:WEED) Still the Best Cannabis Stock to Buy Today?

It has been a quiet few months for the cannabis industry. After starting 2019 on a blistering pace, pot stocks have been consolidating. Since January 15, the Canadian Marijuana Index is relatively flat, up a mere 1%. Over the past three months, the index is down approximately 14% from its 2019 highs reached in mid-March. It is also worth noting that the index is still well below (30%) the euphoria reached last September.

The best time to buy pot stocks is immediately following large price dips and during periods of consolidation. Consolidation is healthy for the industry and is necessary before the next leg up. With that in mind, is industry leader Canopy Growth (TSX:WEED)(NYSE:CGC) still the best in its class? Let’s take a look.

Recent performance

In the industry, I tend to stick with the larger companies. Those who are best positioned to scoop up some of the smaller players in the industry. This distinction used to belong to the trio of Canopy, Aurora Cannabis, and Aphria. Over the past few months, however, the industry has shifted slightly.

Cronos Group has eclipsed Aphria and is now the third-largest TSX-listed pot stock. Likewise, HEXO is now nipping at Aphria’s heels.

That being said, the dominant player in the industry remains Canopy Growth. Year to date, only HEXO (+98%) has surpassed WEED’s 68% price jump. Likewise, over the past month all cannabis stocks are in the negative, mostly by double digits. Once again, Canopy has outperformed the group, losing only 6.81% of its value, second only to Aphria’s small 1% loss.

Recent acquisitions

Canopy has also been actively engaged in strategic acquisitions. In mid-April, the company’s stock soared on news that it had agreed to acquire Acreage Holdings. The deal was lauded by analysts and was a very clever way of entering the U.S. market where cannabis remains illegal at the national level. The deal is complementary to its commitment to build a $150 million hemp processing and production facility in New York State.

The company also made a rather unique acquisition when it purchased This Works in an all-cash deal with $73.8 million. This Works is a leading natural skincare and sleep solutions company that has a loyal customers spanning 35 countries. The deal opens yet another venue for Canopy to expand its product base. It intends to launch a new line of skincare and sleep solution products infused with CBD.

These deals are examples of forward thinking. Canadian recreational cannabis is but one revenue stream. Combined with its tie-up with Constellation Brands, Canopy is quickly becoming one of the more diverse companies in the sector. This will be important, as there are signs of softening in the Canadian recreational marijuana space.

Warning signs ahead

Part of what has been holding pot stocks back has been a recent report from StatsCan that sales of legal cannabis are beginning to flatten. Sales in January and February of this year were flat relative to sales in September and October of 2018. It is important to note, however, that the first few months of legalization have been plagued by numerous logistical headwinds. From packaging to store openings, it hasn’t been the smoothest of roll-outs.

It is for this reason that I am sticking with Canopy Growth as the best stock in the sector. It has kept up with the high flyers and has been less volatile when there are mini-crashes. Although investors aren’t likely to see major impact on financials this year, recent moves towards diversifying operations make this pot stock the one to buy.

You might be missing out on one of the biggest opportunities in Canadian investing history…

Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.

One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.

This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.

Learn More About This TSX Stock Now

More reading

Fool contributor Mat Litalien has no position in any of the stocks mentioned.

Source: The Fool
Is Canopy Growth (TSX:WEED) Still the Best Cannabis Stock to Buy Today?
The Fool

The Motley Fool
Contributor for
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related posts